CD44 and neoplasm: Pancreatic cancer stem cells (PCSC) were identified in 2007, when several groups demonstrated the presence of CD24, CD44, epithelial specific antigen (ESA) triple positive markers or CD133 positive cells had the ability to initiate tumor formation in animals at very low numbers [6, 7].